| ￥3500 | |
| Z05441-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||||
| Protein Construction |
|
||||||
| Purity | > 95% as determined by BisTris PAGE | ||||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
| Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | ||||||
| Expression System | HEK293 | ||||||
| Theoretical Molecular Weight | 21.3 kDa | ||||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 50-70 kDa based on Bis-Tris PAGE result. | ||||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized IL-15RA/IL-15 R alpha/CD215, His & Avi, Human, No Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Human IL-15RA, His Tag with the EC50 of 15.4ng/ml determined by ELISA. »
The purity of IL-15RA/IL-15 R alpha/CD215, His & Avi, Human is greater than 95% as determined by SEC-HPLC. »
IL-15RA/IL-15 R alpha/CD215, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Interleukin-15 receptor alpha (IL-15R alpha) is a high affinity IL-15 binding protein that is crucial for mediating IL-15 functions such as memory CD8 T cell proliferation and NK, NK/T cell, and intestinal intraepithelial lymphocyte development. |
| Synonyms | IL-15 R alpha; CD215; IL-15RA; MGC104179 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
